Aino Co., Ltd. Of North China Pharmaceutical Group FDA Inspection Record

FEI 3004090057 · Inspections, Form 483s, warning letters and import refusals

Aino Co., Ltd. Of North China Pharmaceutical Group is an FDA-registered facility (FEI 3004090057) located in Hebei, CN. Registered operations: API MANUFACTURE. RegDataLab tracks 6 FDA inspections and 1 compliance action at this facility.

What FDA found at this site

Latest inspection
Mar 14, 2025: No Action Indicated (NAI)
Inspections on record
6 (5 VAI, 1 NAI)
Last OAI inspection
None on record
Warning letters
1 listed by FDA for this FEI, latest Aug 30, 2012

A Form 483 lists an inspector's observations. OAI means FDA recommends regulatory and/or administrative action. A warning letter is FDA's formal enforcement notice. No record here does not establish that a site is safe. Check this site on FDA's Data Dashboard.

Inspections and what FDA cited

Newest first. Citations are the inspector observations FDA publishes for the inspection.

DateResultWhat FDA cited
Mar 14, 2025No Action Indicated (NAI)No citations listed
Jan 17, 2019Voluntary Action Indicated (VAI)No citations listed
Apr 29, 2016Voluntary Action Indicated (VAI)No citations listed
Jun 6, 2014Voluntary Action Indicated (VAI)No citations listed
Nov 18, 2011Voluntary Action Indicated (VAI)No citations listed
Jul 2, 2009Voluntary Action Indicated (VAI)No citations listed

FDA record score

2 of 100. A count of this site's adverse public FDA records, weighted by how recent each one is. A higher number means more, or more recent, records. Each record below adds the points shown.

Counted on Nov 14, 2026, method version 1. It counts records and does not judge the site: a low number does not establish that a site is safe, and sites that FDA inspects more often can collect more points. How this is counted.

6 records behind this number
RecordDatePoints x age weightAdds
Inspection classified VAIJan 17, 20196 x 0.251.5
Inspection classified VAIApr 29, 201610 years or older, so it adds no points0
Inspection classified VAIJun 6, 201410 years or older, so it adds no points0
Warning letter on FDA's dashboard, which does not show close-outsAug 30, 201210 years or older, so it adds no points0
Inspection classified VAINov 18, 201110 years or older, so it adds no points0
Inspection classified VAIJul 2, 200910 years or older, so it adds no points0

When each source was last refreshed

FDA sources behind this page and when RegDataLab last refreshed each one
RecordsLast refreshedSource as ofStatus
InspectionsNov 14, 2026Newest record Nov 5, 2026Current
Inspection citationsNov 14, 2026Newest record Nov 5, 2026Current
Compliance actions (warning letters, injunctions and other action types)Nov 2, 2026Newest record Oct 29, 2026Current
Warning letter textNov 14, 2026Newest record Nov 10, 2026Current
Recalls (Enforcement Report)Nov 14, 2026Newest record Nov 11, 2026Current
Form 483s and inspection documentsNov 13, 2026Newest record Nov 12, 2026Current
Import refusalsNov 2, 2026Newest record Oct 22, 2026Current

Reviewing Aino Co., Ltd. Of North China Pharmaceutical Group as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check Aino Co., Ltd. Of North China Pharmaceutical Group yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

Facility details

Company
Aino Co., Ltd. Of North China Pharma. Group
Location
Hebei (CN)
Registration Expires
Dec 31, 2027
Operations
API MANUFACTURE
Source
decrs

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.